Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

C.H. Polman, A. Bertolotto, F. Deisenhammer, G. Giovannoni, H.P. Hartung, B. Hemmer, J. Killestein, H.F. McFarland, J. Oger, A.R. Pachner, J. Petkau, A.T. Reder, S.C. Reingold, H. Schellekens, P.S. Sorensen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)740-750
JournalLancet Neurology
Volume9
Issue number7
DOIs
Publication statusPublished - 2010

Cite this

Polman, C. H., Bertolotto, A., Deisenhammer, F., Giovannoni, G., Hartung, H. P., Hemmer, B., ... Sorensen, P. S. (2010). Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet Neurology, 9(7), 740-750. https://doi.org/10.1016/S1474-4422(10)70103-4